ChemoCentryx, Inc.
CCXI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $2,391,700 | $4,067,401 | $2,250,316 | $543,471 |
| - Cash | $49,978 | $32,297 | $39,179 | $28,088 |
| + Debt | $4,715 | $25,246 | $21,289 | $168,585 |
| Enterprise Value | $2,346,437 | $4,060,350 | $2,232,426 | $683,968 |
| Revenue | $32,224 | $64,891 | $35,952 | $42,875 |
| % Growth | -50.3% | 80.5% | -16.1% | – |
| Gross Profit | $31,922 | $64,891 | $35,952 | $42,875 |
| % Margin | 99.1% | 100% | 100% | 100% |
| EBITDA | -$131,311 | -$51,916 | -$51,698 | -$36,230 |
| % Margin | -407.5% | -80% | -143.8% | -84.5% |
| Net Income | -$129,060 | -$55,356 | -$55,489 | -$37,966 |
| % Margin | -400.5% | -85.3% | -154.3% | -88.6% |
| EPS Diluted | -1.96 | -0.84 | -0.98 | -0.76 |
| % Growth | -133.3% | 14.3% | -28.9% | – |
| Operating Cash Flow | -$75,621 | -$81,143 | -$70,123 | $16,436 |
| Capital Expenditures | -$19,020 | -$15,409 | -$790 | -$838 |
| Free Cash Flow | -$94,641 | -$96,552 | -$70,913 | $15,598 |